Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics

Journal of Alzheimer's Disease

Volumn 19, Issue 4, 2010, Pages 1199-1203

  Zimmermann, Rüdiger ^a   Beck, Georg ^a   Knispel, Sabine ^b   Maler, Juan Manuel ^a   Weih, Markus ^a   Wiltfang, Jens ^c   Kornhuber, Johannes ^a   Lewczuk, Piotr ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Amyloid ; Cerebrospinal fluid; Dementia; Neurodegeneration; Neuroimmunology; Tau

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; LACTIC ACID; TAU PROTEIN;

ADULT; ARTICLE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; DEMENTIA; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 77950361922     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1313     Document Type: Article

References (21)

1. Lewczuk P, Wiltfang J (2008) Neurochemical dementia diagnostics: State of the art and research perspectives. Proteomics 8, 1292-1301.
2. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H (1999) Improved discrimination of AD patients using b-amyloid(1-42) and tau levels in CSF. Neurology 52, 1555-1562.
3. Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, Romero IA,Weksler B, Stanimirovic DB, ZhangW(2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 34, 95-106.
4. Maler JM, Spitzer P, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J (2006) Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support? Mol Psychiatry 11, 1113-1115.
5. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease related data patterns and evaluation programs. J Neurol Sci 184, 101-122.
6. Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, Kornhuber J, Wiltfang J (2004) Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: Original data and reviewof the literature. J Mol Neurosci 23, 115-122.
7. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Eikenberg O, Antz C, Krause WR, Reulbach U, Kornhuber J, Wiltfang J (2004) Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau. Neurobiol Aging 25, 273-281.
8. Andersson M, Alvarez-Cermeno J, BernardiG,Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M, et al. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57, 897-902.
9. Weber T, Major EO (1997) Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40, 98-111.
10. Algotsson A, Winblad B (2007) The integrity of the bloodbrain barrier in Alzheimer's disease. Acta Neurol Scand 115, 403-408.
11. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K (2001) Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297, 187-190.
12. Franz G, Beer R, Kampfl A, Engelhardt K, Schmutzhard E, Ulmer H, Deisenhammer F (2003) Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457-1461.
13. Blennow K, Wallin A, Fredman P, Gottfries CG, Karlsson I, Svennerholm L (1991) Investigation of intrathecal synthesis of immunoglobulin G in primary degenerative dementia (Alzheimer's disease). Dement Geriatr Cogn Disord 2, 30-34.
14. Blennow K,Wallin A, Davidsson P, Fredman P, Gottfries CG, Svennerholm L (1990) Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 4, 79-86.
15. Hampel H,Kotter HU, Padberg F,KorschenhausenDA, Moller HJ (1999) Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord 13, 9-19.
16. Elovaara I, Seppala I, Palo J, Sulkava R, Erkinjuntti T (1988) Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Acta Neurol Scand 77, 397-401.
17. Henkel AW, Dittrich PS, Groemer TW, Lemke EA, Klingauf J, Klafki HW, Lewczuk P, Esselmann H, Schwille P, Kornhuber J, Wiltfang J (2007) Immune complexes of auto-antibodies against Abeta1-42 peptides patrol cerebrospinal fluid of non- Alzheimer's patients. Mol Psychiatry 12, 601-610.
18. Tumani H, Nolker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45, 1663-1670.
19. Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Burger K, Hampel H, Frolich L, Wolf S, Prinz B, Jahn H, Luckhaus C, Perneczky R, Hull M, Schroder J,Kessler H, Pantel J, Gertz H-J, Klafki H-W, Kolsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J (2008) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry, in press.
20. Zetterberg H,Wahlund LO, Blennow K (2003) Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett 352, 67-69.
21. Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kolsch H, Jessen F, Schroder J, Schonknecht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J (2008) Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging 29, 812-818.